Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 475-479

  Yoshida, Madoka ^a   Higashi, Kyohei ^a   Kobayashi, Eiichi ^a   Saeki, Naokatsu ^a   Wakui, Kenji ^b   Kusaka, Tadafumi ^c   Takizawa, Hirotaka ^d   Kashiwado, Koichi ^d   Suzuki, Norikazu ^e   Fukuda, Kazumasa ^f   Nakamura, Takao ^f   Watanabe, Sakae ^g   Tada, Kei ^g   Machi, Yoshiki ^a   Mizoi, Mutsumi ^a   Toida, Toshihiko ^a   Kanzaki, Tetsuto ^h   Tomitori, Hideyuki ^h   Kashiwagi, Keiko ^h   Igarashi, Kazuei ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Chiba Neurosurgical Clinic   (Japan)

^c Kusaka Hospital   (Japan)

^d Portsquare Kashiwado Clinic   (Japan)

^e Suzuki Neurosurgical Clinic   (Japan)

^f Chiba Central Medical Center   (Japan)

^g Saisei Hospital   (Japan)

^h CHIBA INSTITUTE OF SCIENCE   (Japan)

Author keywords

Carotid atherosclerosis; CRP; IL 6; Protein conjugated acrolein; Silent brain infarction; White matter hyperintensity

Indexed keywords

ACROLEIN; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BRAIN INFARCTION; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SILENT BRAIN INFARCTION; WHITE MATTER;

ACROLEIN; ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN DISEASES; BRAIN INFARCTION; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; FEMALE; HUMANS; INTERLEUKIN-6; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEURAL NETWORKS (COMPUTER); RISK FACTORS;

EID: 77955281176     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.031     Document Type: Article

References (28)

1. Igarashi K., Kashiwagi K. Modulation of cellular function by polyamines. Int J Biochem Cell Biol 2010, 42:39-51.
2. Tomitori H., Usui T., Saeki N., et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 2005, 36:2609-2613.
3. Sharmin S., Sakata K., Kashiwagi K., et al. Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys Res Commun 2001, 282:228-235.
4. Sakata K., Kashiwagi K., Sharmin S., et al. Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 2003, 305:143-149.
5. Saiki R., Nishimura K., Ishii I., et al. Intense correlation between brain infarction and protein-conjugated acrolein. Stroke 2009, 40:3356-3361.
6. Kobayashi S., Okada K., Koide H., Bokura H., Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997, 28:1932-1939.
7. Vermeer S.E., Hollander M., van Dijk E.J., et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003, 34:1126-1129.
8. Vermeer S.E., Longstreth W.T., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurol 2007, 6:611-619.
9. Lopez O.L., Jagust W.J., Dulberg C., et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol 2003, 60:1394-1399.
10. Yoshida M., Tomitori H., Machi Y., et al. Acrolein, IL-6 and CRP as markers of silent brain infarction. Atherosclerosis 2009, 203:557-562.
11. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. New Engl J Med 1999, 340:14-22.
12. Inoue K., Matsumoto M., Shono T., Toyokawa S., Moriki A. Increased intima media thickness and atherosclerotic plaques in the carotid artery as risk factors for silent brain infarcts. J Stroke Cerebrovasc Dis 2007, 16:14-20.
13. Bokura H., Kobayashi S., Yamaguchi S., et al. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis 2006, 15:57-63.
14. Uchida K., Kanematsu M., Morimitsu Y., et al. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem 1998, 273:16058-16066.
15. Hoshi T., Kitagawa K., Yamagami H., et al. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005, 36:768-772.
16. Shinohara Y., Tohgi H., Hirai S., et al. Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study). 1. Design and results at enrollment. Cerebrovasc Dis 2007, 24:202-209.
17. Makita S., Nakamura M., Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 2005, 36:2138-2142.
18. Yamagami H., Kitagawa K., Hoshi T., et al. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 2005, 25:1458-1462.
19. Ellenius J., Groth T., Lindahl B., Wallentin L. Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis. Clin Chem 1997, 43:1919-1925.
20. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
21. Brenner H., Gefeller O. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Stat Med 1997, 16:981-991.
22. Kobayashi M., Hirawa N., Yatsu K., et al. Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant 2009, 24:201-207.
23. Gouw A.A., van der Flier W.M., Fazekas F., et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008, 39:1414-1420.
24. Kawamura T., Umemura T., Kanai A., et al. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus. Metabolism 2006, 55:461-466.
25. Fujita T., Tozaki-Saitoh H., Inoue K. P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures. Glia 2009, 57:244-257.
26. Whiteley W., Tseng M.C., Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke 2008, 39:2902-2909.
27. Yoshida M., Higashi K., Jin L., et al. Identification of acrolein-conjugated protein in plasma of patients with brain infarction. Biochem Biophys Res Commun 2010, 391:1234-1239.
28. e{open}-(3-Methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein. J Biol Chem 2003, 278:48658-48665.